Here's the Nuveen portfolio:
Nuveen Biotechnology Five-Year Sector Portfolio, September 1999
Percentage
of
Aggregate Cost of Current
Number of Ticker Offering Market Value Securities to Dividend
Shares Name of Issuer of Securities(1) Symbol Price per Share Portfolio(2) Yield(3)
---------------------------------------------------------------------------------------------------
Instruments Scientific 6.69%
137 PE Corp.-PE Biosystems PEB 6.69% $ 73.3125 $ 10,044 0.46%
Medical-Biomedical/Gene 59.81%
120 Amgen Inc. AMGN 6.61% 82.6875 9,923 N/A
118 Biogen, Inc. BGEN 6.68% 84.9375 10,023 N/A
296 Chiron Corporation CHIR 6.62% 33.5625 9,935 N/A
357 Enzon Inc. ENZN 6.57% 27.6250 9,862 N/A
63 Genentech, Inc. DNA 6.74% 160.5625 10,115 N/A
206 Genzyme Corporation GENZ 6.73% 49.0000 10,094 N/A
96 IDEC Pharmaceuticals Corporation IDPH 6.66% 104.1250 9,996 N/A
203 Immunex Corporation IMNX 6.58% 48.5625 9,858 N/A
152 Millenium Pharmaceuticals, Inc. MLNM 6.62% 65.3750 9,937 N/A
Medical-Drugs 20.06%
98 MedImmune, Inc. MEDI 6.67% 102.0625 10,002 N/A
136 Novartis AG, ADR NVTSY 6.63% 73.1250 9,945 1.11%
203 Schering-Plough Corporation SGP 6.76% 49.9375 10,137 1.00%
Therapeutics 13.44%
133 Gilead Sciences Inc. GILD 6.70% 75.5625 10,050 N/A
128 QLT Photo Therapeutics Inc. QLTI 6.74% 79.0000 10,112 N/A
----- ------ --------
2,446 100% $150,033
===== ====== ========
---------
|
